Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Alaunos Therapeutics 10-K: Revenue $0.005M, Net loss $4.176M
Alaunos Therapeutics reported minimal revenue and a net loss for the year, primarily due to operating expenses. The company has pivoted its programs from oncology to an obesity/metabolic program, which has shown promising preclinical results. Future advancement of this program is contingent on securing additional capital and strategic partnerships.